Loading...
Conduit Pharmaceuticals Inc.
CDTTW•NASDAQ
Healthcare
Biotechnology
$0.01
$0.003(32.98%)
Conduit Pharmaceuticals Inc. (CDTTW) Financial Performance & Statements
Review Conduit Pharmaceuticals Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.00%
Operating Income Growth
4890.72%
↑ 4890.72%
Net Income Growth
37190.28%
↑ 37190.28%
Operating Cash Flow Growth
4563.42%
↑ 4563.42%
Operating Margin
2.82%
↑ 2.82%
Gross Margin
64.55%
↑ 64.55%
Net Profit Margin
1.77%
↑ 1.77%
ROE
6.02%
↑ 6.02%
ROIC
2.30%
↑ 2.30%
Conduit Pharmaceuticals Inc. (CDTTW) Financial Statements
Explore quarterly and annual reports for Conduit Pharmaceuticals Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $1.08B | $244.004M | $604.34M | $535.67M |
| Cost of Revenue | $416.23M | $0.00 | $377.53M | $334.08M |
| Gross Profit | $660.74M | $244.004M | $226.81M | $201.60M |
| Gross Profit Ratio | $0.61 | $1.00 | $0.38 | $0.38 |
| R&D Expenses | $28.97M | $3.09M | $25000.00 | $128000.00 |
| SG&A Expenses | $137.36M | $2.72M | $3.12M | $2.83M |
| Operating Expenses | $166.33M | $5.81M | $3.14M | $2.96M |
| Total Costs & Expenses | $582.56M | $5.81M | $3.14M | $2.96M |
| Interest Income | $0.00 | $0.00 | $2000.00 | $9000.00 |
| Interest Expense | -$10.85M | $310000.00 | $119000.00 | $119000.00 |
| Depreciation & Amortization | $0.00 | -$335000.00 | $0.00 | $26.99M |
| EBITDA | $69.18M | -$6.15M | -$5.26M | -$2.96M |
| EBITDA Ratio | $0.06 | -$0.03 | -$0.005 | -$0.006 |
| Operating Income | $69.18M | -$5.81M | -$3.14M | -$2.96M |
| Operating Income Ratio | $0.06 | -$0.02 | -$0.005 | -$0.006 |
| Other Income/Expenses (Net) | -$11.81M | -$650000.00 | -$2.24M | -$597000.00 |
| Income Before Tax | $57.37M | -$6.46M | -$5.38M | -$3.55M |
| Income Before Tax Ratio | $0.05 | -$0.03 | -$0.009 | -$0.007 |
| Income Tax Expense | $1.01M | -$60.15M | -$11.09M | -$8.36M |
| Net Income | $58.38M | -$6.46M | -$5.38M | -$3.57M |
| Net Income Ratio | $0.05 | -$0.03 | -$0.009 | -$0.007 |
| EPS | $1.43 | $1.24 | -$0.15 | -$0.10 |
| Diluted EPS | $1.41 | $1.24 | -$0.15 | -$0.10 |
| Weighted Avg Shares Outstanding | $40.69M | $43.58M | $36.93M | $36.91M |
| Weighted Avg Shares Outstanding (Diluted) | $41.30M | $43.58M | $36.93M | $36.91M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan